Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635c4

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on April 5, 2023, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 22,000 shares of its common stock to three… Read More

Leave a Reply

Your email address will not be published. Required fields are marked *